Meeting NewsVideo

Assessing patient activation may help customize IBD interventions

LAS VEGAS — In this exclusive video from the Crohn’s & Colitis Congress, David T. Rubin, MD, professor of medicine at the University of Chicago, discusses a presentation given by Edward Barnes, MD, MPH, professor of assistant professor of medicine in the division of gastroenterology and hepatology at University of North Carolina, Chapel Hill, on patient activation, a measure of a patient’s knowledge and confidence in managing their health.

“Barnes and colleagues used a validated instrument called the Patient Activation Measure to assess patients’ levels of activation, which refers to their behavioral willingness to make changes,” Rubin said.

The example used in the presentation was smoking cessation, he said.

“It was very interesting to be able to assess how patients are either activated or not activated as it may relate to being adherent to therapy, making changes in their lifestyle and treating their disease, and how we might learn from this to develop some customized interventions to help patients become more in touch with their disease and self-reliant,” he said.

He also noted the study’s use of the Crohn’s & Colitis Foundation Partners database, an internet-based database for patients.

“This is a really interesting topic — excellent presentation by Barnes and his colleagues, and a great use of the Crohn’s and Colitis Foundation’s resource,” Rubin said.

Reference:

Barnes E, et al. Abstract 12. Presented at: Crohn’s & Colitis Congress; Jan. 19-20, 2018; Las Vegas, NV.

Disclosures: Rubin reports no relevant financial disclosures.

LAS VEGAS — In this exclusive video from the Crohn’s & Colitis Congress, David T. Rubin, MD, professor of medicine at the University of Chicago, discusses a presentation given by Edward Barnes, MD, MPH, professor of assistant professor of medicine in the division of gastroenterology and hepatology at University of North Carolina, Chapel Hill, on patient activation, a measure of a patient’s knowledge and confidence in managing their health.

“Barnes and colleagues used a validated instrument called the Patient Activation Measure to assess patients’ levels of activation, which refers to their behavioral willingness to make changes,” Rubin said.

The example used in the presentation was smoking cessation, he said.

“It was very interesting to be able to assess how patients are either activated or not activated as it may relate to being adherent to therapy, making changes in their lifestyle and treating their disease, and how we might learn from this to develop some customized interventions to help patients become more in touch with their disease and self-reliant,” he said.

He also noted the study’s use of the Crohn’s & Colitis Foundation Partners database, an internet-based database for patients.

“This is a really interesting topic — excellent presentation by Barnes and his colleagues, and a great use of the Crohn’s and Colitis Foundation’s resource,” Rubin said.

Reference:

Barnes E, et al. Abstract 12. Presented at: Crohn’s & Colitis Congress; Jan. 19-20, 2018; Las Vegas, NV.

Disclosures: Rubin reports no relevant financial disclosures.

    See more from Crohn's & Colitis Congress